Skip to content
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) Q1 2024 Earnings

EDSA·Reported May 10, 2024·Before market open

Diluted EPS came in at $-0.58, beat the $-0.69 consensus by $0.11.

Diluted EPS
$-0.58beat by $0.11
Consensus: $-0.69
SEC

SEC Filings

Earnings release8-K not filed yet

Financial Snapshot

Trailing eight quarters through Q1 2024

Q1 2024 Earnings FAQ

Common questions about Edesa Biotech, Inc.'s Q1 2024 earnings report.

Edesa Biotech, Inc. (EDSA) reported Q1 2024 earnings on May 10, 2024 before market open.

Edesa Biotech, Inc. reported diluted EPS of $-0.58 for Q1 2024.

EPS beat the consensus estimate of $-0.69 by $0.11.

You can read the 10-Q periodic report (0001654954-24-005971) directly on SEC EDGAR. The filing index links above go to sec.gov.